The restoration of miR-1 promotes the expression of Bax and E-cadherin and decreases the expression of BCL2, MMP2 and MMP9, apparently impairing the invasion and migration of CRC cells in synergy with radiotherapy [426]. The gene discussed is BCL2; the disease is colorectal carcinoma.